ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,339, issued on May 26, was assigned to ROUSSELOT B.V. (Ghent, Belgium).

"Hydrolyzed collagen for use in reducing blood glucose" was invented by Kristof Robert Callemin (Ghent, Belgium), Elien Monique Gevaert (Ghent, Belgium), Arne Goes (Ghent, Belgium), Janne Prawitt (Ghent, Belgium) and Sara Vleminckx (Ghent, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a hydrolyzed collagen formulation for use in decreasing blood glucose. The hydrolyzed collagen is obtained by enzymatic hydrolysis of a collagen-containing material with a combination of enzymes comprising two or more enzymes selected from the group consisti...